Back to the future in Chagas disease: From animal models to patient cohort studies, progress in immunopathogenesis research

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 187-198

  Scharfstein, Julio ^a   Gomes, Juliana de Assis Silva ^b   Correa Oliveira, Rodrigo ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cardiomyopathy; Chagas disease; T cells; Trypanosoma cruzi

Indexed keywords

ANIMALIA; TRYPANOSOMA CRUZI;

EID: 68949212148     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900025     Document Type: Article

References (120)

1. Acosta DM, Arnaiz MR, Esteva MI, Barboza M, Stivale D, Orlando UD, Torres S, Laucella SA, Couto AS, Duschak VG 2008. Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice. Int Immunol 20: 461-470.
2. Affranchino JL, Ibañez CF, Luquetti AO, Rassi A, Reyes MB, Macina RA, Aslund L, Pettersson U, Frasch AC 1989. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Mol Biochem Parasitol 34: 221-228.
3. +T cells in chronic Chagas' disease patients Int Immunol 18: 465-471.
4. Aliberti J, Viola JP, Vieirade-Abreu A, Bozza PT, Sher A, Scharfstein J 2003. Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J Immunol 170: 5349-5353.
5. Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, Farber J, Gazzinelli RT, Silva JS 2001. Modulation of chemokine production and inflammatory responses in interferon-gamma-and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
6. Almeida IC, Gazzinelli RT 2001. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J Leukoc Biol 70: 467-477.
7. +T cells in chronic Chagas disease. PLoS Negl Trop Dis 2: e288.
8. Andrade SG 1999. Trypanosoma cruzi: clonal structure of parasite strains and the importance of principal clones. Mem Inst Oswaldo Cruz 94 (Suppl. I): 185-187.
9. Andrade ZA, Andrade SG, Correa R, Sadigursky M, Ferrans VJ 1994. Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy. Am J Pathol 144: 1403-1411.
10. Añez N, Crisante G, da Silva FM, Rojas A, Carrasco H, Umezawa ES, Stolf AM, Ramírez JL, Teixeira MM 2004. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas' disease. Trop Med Int Health 9: 1319-1326.
11. HIGH regulatory T cells in morbidity in Chagas' disease. Front Biosci 12: 2797-2806.
12. Arnholdt AC, Piuvezam MR, Russo DM, Lima AP, Pedrosa RC, Reed SG, Scharfstein J 1993. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J Immunol 151: 3171-3179.
13. Ashton AW, Mukherjee S, Nagajyothi FN, Huang H, Braunstein VL, Desruisseaux MS, Factor SM, Lopez L, Berman JW, Wittner M, Scherer PE, Capra V, Coffman TM, Serhan CN, Gotlinger K, Wu KK, Weiss LM, Tanowitz HB 2007. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 204: 929-940.
14. Baetz A, Frey M, Heeg K, Dalpke AH 2004. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J Biol Chem 279: 54708-54715.
15. Barboza M, Duschak VG, Fukuyama Y, Nonami H, Erra-Balsells R, Cazzulo JJ, Couto AS 2005. Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides. FEBS J 272: 3803-3815.
16. Benvenuti LA, Roggério A, Freitas HF, Mansur AJ, Fiorelli A, Higuchi ML 2008. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 102: 481-487.
17. Briones MR, Souto RP, Stolf BS, Zingales B 1999. The evolution of two Trypanosoma cruzi subgroups inferred from rRNA genes can be correlated with the interchange of American mammalian faunas in the Cenozoic and has implications to pathogenicity and host specificity. Mol Biochem Parasitol 104: 219-232.
18. Brisse S, Dujardin JC, Tibayrenc M 2000. Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol 111: 95-105.
19. Burgos JM, Begher SB, Freitas JM, Bisio M, Duffy T, Altcheh J, Teijeiro R, Lopez Alcoba H, Deccarlini F, Freilij H, Levin MJ, Levalle J, Macedo AM, Schijman AG 2005. Molecular diagnosis and typing of Trypanosoma cruzi populations and lineages in cerebral Chagas disease in a patient with AIDS. Am J Trop Med Hyg 73: 1016-1018.
20. Burgos N, Hernandez-Reif M, Mendoza R, Castillo R 2007. Caregivers' perception of HIV-infected Dominican children's behavior. West Indian Med J 56: 42-47.
21. +T central memory response in chronic Chagas disease. Nat Med 14: 542-550.
22. Calzada JE, Nieto A, Beraún Y, Martín J 2001. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 58: 154-158.
23. Cazzulo JJ, Stoka V, Turk V 1997. Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi. Biol Chem 378: 1-10.
24. Coronado X, Zulantay I, Reyes E, Apt W, Venegas J, Rodriguez J, Solari A, Sanchez G 2006. Comparison of Trypanosoma cruzi detection by PCR in blood and dejections of Triatoma infestans fed on patients with chronic Chagas disease. Acta Trop 98: 314-317.
25. Costa GC, da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ, Dutra WO 2009. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 199: 451-454.
26. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM 2006. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39: 41-54.
27. D'Avila DA, Guedes PM, Castro AM, Gontijo ED, Chiari E, Galvão LM 2009. Immunological imbalance between IFN-γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Mem Inst Oswaldo Cruz 104: 100-105.
28. De Freitas JM, Augusto-Pinto L, Pimenta JR, Bastos-Rodrigues L, Gonçalves VF, Teixeira SM, Chiari E, Junqueira AC, Fernandes O, Macedo AM, Machado CR, Pena SD 2006. Ancestral genomes, sex and the population structure of Trypanosoma cruzi. PLoS Pathog 2: e24.
29. De Meis J, Ferreira LM, Guillermo LV, Silva EM, Dosreis GA, Lopes MF 2008. Apoptosis differentially regulates mesenteric and sub-cutaneous lymph node immune responses to Trypanosoma cruzi. Eur J Immunol 38: 139-146.
30. Del Nery E, Juliano MA, Lima AP, Scharfstein J, Juliano L 1997. Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi. J Biol Chem 272: 25713-25718.
31. Dias WB, Fajardo FD, Graça-Souza AV, Freire-de-Lima L, Vieira F, Girard MF, Bouteille B, Previato JO, Mendonça-Previato L, To-deschini AR 2008. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi. Cell Microbiol 10: 88-99.
32. Dos Reis GA, Freire-de-Lima CG, Nunes MP, Lopes MF 2005. The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol 21: 237-243.
33. Duthie MS, Cetron MS, Van Voorhis WC, Kahn SJ 2005. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes. Acta Trop 3: 317-329.
34. Fernandes AB, Mortara RA 2004. Invasion of MDCK epithelial cells with altered expression of Rho GTPases by Trypanosoma cruzi amastigotes and metacyclic trypomastigotes of strains from the two major phylogenetic lineages. Microbes Infect 6: 460-467.
35. +epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect 7: 688-697.
36. Fernandes AB, Mortara RA 2004. Invasion of MDCK epithelial cells with altered expression of Rho GTPases by Trypanosoma cruzi amastigotes and metacyclic trypomastigotes of strains from the two major phylogenetic lineages. Microbes Infect 6: 460-467.
37. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199-203.
38. +T-cell epitopes are important for efficient protective immunity induced by DNA Lima AP, dos Reis FC, Serveau C, Lalmanach G, Juliano L, Ménard vaccination with a Trypanosoma cruzi gene. Infect Immun 69: 5477-5486.
39. Garg N, Tarleton RL 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun 70: 5547-5555.
40. Girones N, Fresno M 2003. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol 19: 19-22.
41. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R 2005. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960-7966.
42. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R 2003. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
43. +cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology 102: 209-217.
44. Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, Manning JE 2006. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74: 135-143.
45. +T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
46. Higuchi ML, Fukasawa S, De Brito T, Parzianello LC, Bellotti G, Ramires JA 1999. Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 82: 279-285.
47. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, Mc-Curley TL 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
48. Kahn SJ, Wleklinski M 1997. The surface glycoproteins of Trypanosoma cruzi encode a superfamily of variant T cell epitopes. J Immunol 159: 4444-4451.
49. Kierszenbaum F 1986. Autoimmunity in Chagas' disease. J Parasitol 72: 201-211.
50. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL 2004. Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909-918.
51. +T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol 170: 2264-2268.
52. Leon JS, Engman DM 2003. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front Biosci 8: 15-22.
53. Libby P, Alroy J, Pereira ME 1986. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J Clin Invest 77: 127-135.
54. Lima AP, Almeida PC, Tersariol IL, Schmitz V, Schmaier AH, Juliano L, Hirata IY, Müller-Esterl W, Chagas JR, Scharfstein J 2002. Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J Biol Chem 277: 5875-5881.
55. Macedo AM, Oliveira RP, Pena SD 2002. Chagas disease: role of parasite genetic variation in pathogenesis. Expert Rev Mol Med 4: 1-16.
56. Macedo AM, Pena SD 1998. Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease. Parasitol Today 14: 119-124.
57. Machado FS, Koyama NS, Carregaro V, Ferreira BR, Milanezi CM, Teixeira MM, Rossi MA, Silva JS 2005. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 191: 627-636.
58. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS 2000. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102: 3003-3008.
59. +CD25+T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 10: 825-833.
60. Marino AP, da Silva A, dos Santos P, Pinto LM, Gazzinelli RT, Teixeira MM, Lannes-Vieira J 2004. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 110: 1443-1449.
61. +T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2: e77.
62. Mathieu-Daudé F, Bosseno MF, Garzon E, Lelièvre J, Sereno D, Ouaissi A, Brenière SF 2007. Sequence diversity and differential expression of Tc52 immuno-regulatory protein in Trypanosoma cruzi: potential implications in the biological variability of strains. Parasitol Res 101: 1355-1363.
63. Medeiros GA, Silvério JC, Marino AP, Roffê E, Vieira V, Kroll-Palhares K, Carvalho CE, Silva AA, Teixeira MM, Lannes-Vieira J 2009. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. Microbes Infect 11: 264-273.
64. Medeiros MM, Peixoto JR, Oliveira AC, Cardilo-Reis L, Koatz VL, Van Kaer L, Previato JO, Mendonça-Previato L, Nobrega A, Bellio M 2007. Toll-like receptor 4 (TLR4)-dependent proinflammatory and immunomodulatory properties of the glycoinositolphospholipid (GIPL) from Trypanosoma cruzi. J Leukoc Biol 82: 488-496.
65. Mengel JO, MA Rossi 1992. Chronic chagasic myocarditis pathogenesis: dependence on autoimmune and microvascular factors. Am Heart J 124: 1052-1057.
66. Miles MA, Souza A, Povoa M, Shaw JJ, Lainson R, Toye PJ 1978. Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas' disease in Amazonian Brazil. Nature 272: 819-821.
67. Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y 2001. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 114: 207-212.
68. Monteiro AC, Schmitz V, Morrot A, de Arruda LB, Nagajyothi F, Granato A, Pesquero JB, Müller-Esterl W, Tanowitz HB, Scharfstein J 2008. Bradykinin B2 receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog 3: e185.
69. Monteiro AC, Schmitz V, Svensjo E, Gazzinelli RT, Almeida IC, Todorov A, de Arruda LB, Torrecilhas AC, Pesquero JB, Morrot A, Bouskela E, Bonomo A, Lima AP, Müller-Esterl W, Scharfstein J 2006. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. J Immunol 177: 6325-6335.
70. Morris SA, Tanowitz H, Wittner M, Bilezikian JP 1990. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 82: 1900-1910.
71. Morrot A, Strickland DK, Higuchi Mde L, Reis M, Pedrosa R, Scharfstein J 1997. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multi-functional alpha 2-macroglobulin receptor in antigen presentation by monocytes. Int Immunol 9: 825-834.
72. Murta AC, Persechini PM, Padron Tde S, de Souza W, Guimarães JA, Scharfstein J 1990. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol Biochem Parasitol 43: 27-38.
73. Nakayasu ES, Yashunsky DV, Nohara LL, Torrecilhas AC, Nikolaev AV, Almeida IC 2009. GPIomics: global analysis of glycosylphosphatidylinositol-anchored molecules of Trypanosoma cruzi. Mol Syst Biol 5: 261.
74. Ouaissi A, Guilvard E, Delneste Y, Caron G, Magistrelli G, Herbault N, Thieblemont N, Jeannin P 2002. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. J Immunol 168: 6366-6374.
75. Palomino SA, Aiello VD, Higuchi ML 2000. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 94: 571-579.
76. Petray P, Corral R, Meckert P, Laguens R 2002. Role of macrophage inflammatory protein-1alpha (MIP-1alpha) in macrophage homing in the spleen and heart pathology during experimental infection with Trypanosoma cruzi. Acta Trop 83: 205-211.
77. Proudfoot AEI 2002. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2: 106-115.
78. +lymphocytes. Am J Trop Med Hyg 43: 637-644.
79. Ribeiro-dos-Santos R, Hudson L 1981. Denervation and the immune response in mice infected with Trypanosoma cruzi. Clin Exp Immunol 44: 349-354.
80. +T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol 23: 93-101.
81. Ribeiro-dos-Santos R, Rossi MA, Laus JL, Silva JS, Savino W, Mengel J 1992. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175: 29-39.
82. +T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 57: 2640-2644.
83. Ropert C, Gazzinelli RT 2007. Innate recognition, cell signaling and proinflammatory responses during infection with Trypanosoma cruzi. In EY Denkers, RT Gazzinelli (eds.), Protozoans in macrophages, Landes Biosciences, Austin, p. 49-66.
84. Rossi MA 1990. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 10: 233-236.
85. Ruíz-Sánchez R, León MP, Matta V, Reyes PA, López R, Jay D, Monteón VM 2005. Trypanosoma cruzi isolates from Mexican and Guatemalan acute and chronic chagasic cardiopathy patients belong to Trypanosoma cruzi I. Mem Inst Oswaldo Cruz 100: 281-283.
86. Scharfstein J, Lima AP 2008. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi. Subcell Biochem 47: 140-154.
87. Scharfstein J, Luquetti A, Murta AC, Senna M, Rezende JM, Rassi A, Mendonça-Previato L 1985. Chagas' disease: serodiagnosis with purified Gp25 antigen. Am J Trop Med Hyg 34: 1153-1160.
88. Scharfstein J, Monteiro AC, Schmitz V, Svensjö E 2008. Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway. Biol Chem 389: 1015-1024
89. Scharfstein J, Morrot A 1999. A role for extracellular amastigotes in the immunopathology of Chagas disease. Mem Inst Oswaldo Cruz 94 (Suppl. I): 51-63.
90. Scharfstein J, Rodrigues MM, Alves CA, de Souza W, Previato JO, Mendonça-Previato L 1983. Trypanosoma cruzi: description of a highly purified surface antigen defined by human antibodies. J Immunol 131: 972-976.
91. Scharfstein J, Schechter M, Senna M, Peralta JM, Mendonça-Previato L, Miles MA 1986. Trypanosoma cruzi: characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and bloodstream trypomastigotes. J Immunol 137: 1336-1341.
92. Scharfstein J, Schmitz V, Morandi V, Capella MM, Lima AP, Morrot A, Juliano L, Müller-Esterl W 2000. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med 192: 1289-1300.
93. Scharfstein J, Schmitz V, Svensjö E, Granato A, Monteiro AC 2007. Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. Scand J Immunol 66: 128-136.
94. Schmitz V, Svensjö E, Serra RR, Teixeira MM, Scharfstein J 2009. Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors. J Leukoc Biol 85: 1005-1014.
95. Smulski C, Labovsky V, Levy G, Hontebeyrie M, Hoebeke J, Levin MJ 2006. Structural basis of the cross-reaction between an anti-body to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor. FASEB J 20: 1396-1406.
96. Soares MB, Pontes-De-Carvalho L, Ribeiro-Dos-Santos R 2001. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 73: 547-559.
97. Solari A, Campillay R, Ortíz S, Wallace A 2001. Identification of Trypanosoma cruzi genotypes circulating in Chilean chagasic patients. Exp Parasitol 97: 226-233.
98. Souto RP, Fernandes O, Macedo AM, Campbell DA, Zingales B 1996. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 83: 141-152.
99. Souto RP, Zingales B 1993. Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. Mol Biochem Parasitol 62: 45-52.
100. Souza PE, Rocha MO, Menezes CA, Coelho JS, Chaves AC, Gollob KJ, Dutra WO 2007. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Infect Immun 75: 1886-1894.
101. Talvani A, Ribeiro CS, Aliberti JC, Michailowsky V, Santos PV, Murta SM, Romanha AJ, Almeida IC, Farber J, Lannes-Vieira J, Silva JS, Gazzinelli RT 2000. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2: 851-866.
102. Tanowitz HB, Burns ER, Sinha AK, Kahn NN, Morris SA, Factor SM, Hatcher VB, Bilezikian JP, Baum SG, Wittner M 1990. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 43: 274-281.
103. Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, Weiss LM, Factor SM, Shtutin V, Mukherjee S, Kitsis RN, Christ GJ, Wittner M, Shirani J, Kisanuki YY, Yanagisawa M 2005. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 73: 2496-2503.
104. Tarleton RL 2003. Chagas disease: a role for autoimmunity. Trends Parasitol 19: 447-451.
105. Tarleton RL, Sun J, Zhang L, Postan M 1994. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun 62: 1820-1829.
106. Tibayrenc M, Ayala FJ 1987. Trypanosoma cruzi populations: more clonal than sexual. Parasitol Today 3: 189-190.
107. Todeschini AR, Girard MF, Wieruszeski JM, Nunes MP, Dos Reis GA, Mendonca-Previato L, Previato JO 2002a. Trans-Sialidase from Trypanosoma cruzi binds host T-lymphocytes in a lectin manner. J Biol Chem 277: 45962-45968.
108. Todeschini AR, Nunes MP, Pires RS, Lopes MF, Previato JO, Mendonça-Previato L, Dos Reis GA 2002b. Costimulation of host T lymphocytes by a trypanosomal trans-sialidase: involvement of CD43 signaling. J Immunol 168: 5192-5198.
109. Todorov AG, Andrade D, Pesquero JB, Araujo Rde C, Bader M, Stewart J, Gera L, Müller-Esterl W, Morandi V, Goldenberg RC, Neto HC, Scharfstein J 2003. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J 17: 73-75.
110. Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV 1997a. Cytokine gene polymorphism and heart transplant rejection. Transplantation 64: 776-779.
111. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV 1997b. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8.
112. +T cells leading to immunodominance. J Immunol 180: 1737-1748.
113. Vago AR, Andrade LO, Leite AA, d'Avila Reis D, Macedo AM, Adad SJ, Tostes S Jr, Moreira MC, Filho GB, Pena SD 2000. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol 156: 1805-1809.
114. Vago AR, Macedo AM, Oliveira RP, Andrade LO, Chiari E, Galvão LM, Reis D, Pereira ME, Simpson AJ, Tostes S, Pena SD 1996. Kinetoplast DNA signatures of Trypanosoma cruzi strains obtained directly from infected tissues. Am J Pathol 149: 2153-2159.
115. Venegas J, Coñoepan W, Pichuantes S, Miranda S, Apt W, Arribada A, Zulantay I, Coronado X, Rodriguez J, Reyes E, Solari A, Sanchez G 2009. Differential distribution of Trypanosoma cruzi clones in human chronic chagasic cardiopathic and non-cardio-pathic individuals Acta Trop 109: 187-193.
116. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF 1998. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 66: 4690-4695.
117. +TC1 responses. J Immunol 159: 6120-6130.
118. Wizel B, Palmieri M, Mendoza C, Arana B, Sidney J, Sette A, Tarleton R 1998. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest 102: 1062-1071.
119. Zhang L, Tarleton RL 1996. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp Parasitol 84: 203-213.
120. Zingales B, Stolf BS, Souto RP, Fernandes O, Briones MR 1999. Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. Mem Inst Oswaldo Cruz 94 (Suppl. I): 159-164.